Page last updated: 2024-11-04
sennoside a&b and Cancer Pain
sennoside a&b has been researched along with Cancer Pain in 1 studies
Cancer Pain: Pain that may be caused by or related to cellular, tissue, and systemic changes that occur during NEOPLASM growth, tissue invasion, and METASTASIS.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|
| "Outpatients ≥ 18 years old with cancer, at risk of or already experiencing opioid-induced constipation, were randomly assigned to begin a standard bowel protocol of escalating doses of sennosides or PEG, plus a dummy preparation." | 2.94 | PEG vs. sennosides for opioid-induced constipation in cancer care. ( Gobbo, M; Hawley, P; MacKenzie, H, 2020) |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
Authors
| Authors | Studies |
|---|
| Hawley, P | 1 |
| MacKenzie, H | 1 |
| Gobbo, M | 1 |
Clinical Trials (1)
Trial Overview
| Trial | Phase | Enrollment | Study Type | Start Date | Status |
|---|
| OMAMA-study - Prevention of Opioid-induced Constipation in Patients With Advanced Cancer[NCT05216328] | Phase 4 | 330 participants (Anticipated) | Interventional | 2022-12-02 | Recruiting |
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Trials
1 trial available for sennoside a&b and Cancer Pain